Results 11 to 20 of about 14,196 (217)
Congenital Portosystemic Shunt: Our Experience [PDF]
Case Reports in Pediatrics, 2015 Introduction. Congenital portosystemic venous malformations are rare abnormalities in which the portal blood drains into a systemic vein and which are characterized by extreme clinical variability. Case Presentations. The authors present two case reports
Tiziana Timpanaro +7 more
doaj +3 more sources
Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS
Hepatology, EarlyView., 2022 The river diagram demonstrates that after transjugular intrahepatic portosystemic shunt insertion (TIPS) the majority of patients without ascites and 50% of the patients with ascites detectable at ultrasound, show the best response in the long term follow‐up.
Alexander Queck +14 more
wiley +1 more source
Health disparities in chronic liver disease
Hepatology, EarlyView., 2022 Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian +3 more
wiley +1 more source
Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis
Hepatology, EarlyView., 2022 Diagram of the activation of the profibrotic and procontractile Janus kinase 2 (JAK2)/Ras homolog family member A/Rho‐kinase pathway and the inhibition of phosphorylated JAK2 by pacritinib to inhibit hepatic stellate cell activity. Abstract Background and Aims Janus kinase 2 (JAK2) signaling is increased in human and experimental liver fibrosis with ...
Sandra Torres +21 more
wiley +1 more source
Congenital portosystemic venous shunt [PDF]
European Journal of Pediatrics, 2017 Congenital portosystemic venous shunts are rare developmental anomalies resulting in diversion of portal flow to the systemic circulation and have been divided into extra- and intrahepatic shunts. They occur during liver and systemic venous vascular embryogenesis and are associated with other congenital abnormalities. They carry a higher risk of benign
Michail Pizanias +2 more
openaire +2 more sources
The influence of propanolol on portosystemic shunting [PDF]
Hepatology, 1991 We investigated the role of early portal hypotensive pharmacotherapy in preventing the development of portal-systemic shunting in a portal hypertensive model of chronic murine schistosomiasis induced by infecting C3H mice with 60 cercariae of Schistosoma mansoni. Propranolol was administered in drinking water to 20 animals for
Gumucio, Jorge J., Blendis, Laurence M.
openaire +4 more sources
Transjugular Intrahepatic Portosystemic Shunt [PDF]
Clinics in Liver Disease, 2014 Transjugular intrahepatic portosystemic shunt (TIPS) is an established procedure for the complications of portal hypertension. The largest body of evidence for its use has been supported for recurrent or refractory variceal bleeding and refractory ascites.
Arun J. Sanyal +2 more
openaire +3 more sources
BMC Gastroenterology, 2023 Background This study aimed to investigate the safety, preliminary clinical experience, and technical advantages of double C-arm digital subtraction angiography -assisted portal vein puncture for transjugular intrahepatic portosystemic shunt.
Jianqiao Chen +4 more
doaj +1 more source
Congenital portosystemic shunt occlusion with an Amplatzer PFO occlusion device: a case report
CVIR Endovascular, 2021 Background Congenital portosystemic shunts are embryological malformations in which portal venous flow is diverted to the systemic circulation. High morbidity and mortality are seen in patients with concurrent hepatic encephalopathy, hepatopulmonary ...
Michelle M. Shnayder +3 more
doaj +1 more source
Asymptomatic congenital intrahepatic portosystemic shunt
Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, 2022 Spontaneous asymptomatic intrahepatic portosystemic shunt is a rare anomaly of the hepatic vasculature. The main clinical manifestations may be encephalopathy, bleeding or hyperinsulinism, due to the constant shedding of blood.
E. A. Sidorov +3 more
doaj +1 more source